Emmitec WL1 对比 Rhythm360 for Providers 的使用情况和统计数据

Health, Wellness and Fitness App Vital signs are gathered from standard, non medical of the shelf BLE 4.0 or newer gadgets for uploading information to user's account. No data is stored in iPhone. All data is handled encrypted in the servers. App is 100% HIPAA Compliance. Users can edit and/or delete their accounts directly from the App. New gadgets are being incorporated constantly, the list of actual gadgets included in this app can be found in gadget's list in the app. Please seek a doctor’s advice in addition to using this app and before making any medical decisions. Jurisdiction Statement. This application is intended for use only with medical devices that have been approved by recognized regulatory authorities, such as the FDA (United States), European Union regulatory bodies, ANVISA (Brazil), and other relevant certification organizations, as applicable in different regions (e.g., Americas, Europe). For detailed information about compliance and certification, please refer to the certification information provided via the link above. This App can be used in the USA, North, Central and South America and Europe, according to all the certifications granted to the BLE Gadgets from the FDA, EU (European Regulations) and Anvisa. For more information, there are links in the app where all certifications can be found.
  • Apple 应用商店
  • 免费
  • 健康与健身

商店排名

- -

Rhythm360 is a cloud-based universal cardiac data platform for implanted devices, wearables, and at-home connected devices that lets clinicians incorporate notation, e-signing, and billing into their everyday clinical for managing cardiac data. This app is for providers only.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Emmitec WL1与Rhythm360 for Providers排名比较

对比 Emmitec WL1 与 Rhythm360 for Providers 在过去 28 天内的排名趋势

排名

没有可用的数据

Emmitec WL1 对比 Rhythm360 for Providers 的排名,按国家/地区比较

对比 Emmitec WL1 与 Rhythm360 for Providers 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
Emmitec WL1 VS.
Rhythm360 for Providers

十二月 23, 2024